Aclaris Therapeutics (ACRS) Return on Capital Employed Growth (3y) (2018 - 2026)
Aclaris Therapeutics (ACRS) Return on Capital Employed Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | - |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 4,853.00 |
| 10 | Aclaris Therapeutics | 694.93 Mn | 589.51 Mn | 1.60 Mn | -782.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -782.00 |
| Dec 31, 2025 | -1,724.00 |
| Sep 30, 2025 | -6,477.00 |
| Jun 30, 2025 | -5,272.00 |
| Mar 31, 2025 | -3,911.00 |
| Dec 31, 2024 | -4,533.00 |
| Sep 30, 2024 | 89.00 |
| Jun 30, 2024 | -1,075.00 |
| Mar 31, 2024 | 1,080.00 |
| Dec 31, 2023 | 3,513.00 |
| Sep 30, 2023 | 2,232.00 |
| Jun 30, 2023 | 3,877.00 |
| Mar 31, 2023 | 8,428.00 |
| Dec 31, 2022 | 6,631.00 |
| Sep 30, 2022 | 4,539.00 |
| Jun 30, 2022 | 2,509.00 |
| Mar 31, 2022 | 971.00 |
| Dec 31, 2021 | 1,628.00 |
| Sep 30, 2021 | 2,380.00 |
| Jun 30, 2021 | 1,296.00 |